A Texas Judge has rejected a request from Texas Attorney General Ken Paxton to issue a temporary order barring Tylenol’s maker, Kenvue, from claiming amid litigation that the pain and fever medication is safe for pregnant women and children, according to court documents.
In records filed Friday, District Judge LeAnn Rafferty, in Panola County, also rejected Paxton’s unusual request to block Kenvue from distributing $400 million in dividends to shareholders later this month.
The denials are early losses for Paxton in a politically charged case that hinges on the unproven claim that Tylenol causes autism and other disorders—a claim first introduced by President Trump and his anti-vaccine health secretary, Robert F. Kennedy Jr.
In a bizarre press conference in September, Trump implored Americans repeatedly not to take the drug. But, scientific studies have not shown that Tylenol (acetaminophen) causes autism or other neurologic disorders. Some studies have claimed to find an association between Tylenol use and autism, but the studies have significant flaws, and others have found no link. Moreover, Tylenol is considered the safest pain and fever drug for use during pregnancy, and untreated pain and fevers in pregnancy are known to cause harms, including an increased risk of autism.
Still, Paxton filed the lawsuit October 28, claiming that Kenvue and Tylenol’s former parent company, Johnson & Johnson, deceptively marketed Tylenol as safe while knowing of an increased risk of autism and other disorders. The lawsuit sought to force Kenvue to change the way it markets Tylenol and pay fines, among other requests.
